{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,2]],"date-time":"2026-08-02T22:06:42Z","timestamp":1785708402976,"version":"3.56.0"},"reference-count":8,"publisher":"Wiley","issue":"12","license":[{"start":{"date-parts":[[2007,10,18]],"date-time":"2007-10-18T00:00:00Z","timestamp":1192665600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Euro J of Neurology"],"published-print":{"date-parts":[[2007,12]]},"abstract":"<jats:p>We investigated the incidence and clinical features of patients with myasthenia gravis (MG) associated with autoimmune diseases. Associated autoimmune diseases were found in 28 of 142 consecutive Japanese MG patients (19.7%), amongst which Graves\u2019 disease (7.7%) and Hashimoto's thyroiditis (4.2%) were predominant. The clinical features of MG patients with Graves\u2019 disease were different from those of MG patients without autoimmune diseases in terms of age at onset of MG symptoms (35.5\u2003\u00b1\u20034.0\u2003years and 49.0\u2003\u00b1\u20031.7\u2003years; <jats:italic>P<\/jats:italic>\u2003&lt;\u20030.05), positivity for the anti\u2010acetylcholine receptor antibody (44.4% and 89.8%; <jats:italic>P<\/jats:italic>\u2003&lt;\u20030.05), and association with thymic hyperplasia (72.7 and 17.9%; <jats:italic>P<\/jats:italic>\u2003&lt;\u20030.05). The therapeutic outcome of MG patients with Graves\u2019 disease and that of those without autoimmune diseases were not significantly different. Further studies should be performed to investigate whether MG associated with Graves\u2019 disease is a distinct subtype of MG.<\/jats:p>","DOI":"10.1111\/j.1468-1331.2007.01978.x","type":"journal-article","created":{"date-parts":[[2007,10,18]],"date-time":"2007-10-18T12:28:46Z","timestamp":1192710526000},"page":"1403-1404","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":52,"title":["Clinical features of patients with myasthenia gravis associated with autoimmune diseases"],"prefix":"10.1111","volume":"14","author":[{"given":"M.","family":"Kanazawa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Shimohata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Nishizawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2007,10,18]]},"reference":[{"key":"e_1_2_5_2_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(03)00306-5"},{"key":"e_1_2_5_3_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0404.1989.tb03881.x"},{"key":"e_1_2_5_4_2","first-page":"193","article-title":"Associated autoimmune disease in myasthenia gravis","volume":"91","author":"Christensen PB","year":"1995","journal-title":"Acta Neurologica Scandinavica"},{"key":"e_1_2_5_5_2","doi-asserted-by":"publisher","DOI":"10.1210\/jc.82.2.438"},{"key":"e_1_2_5_6_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.55.1.16"},{"key":"e_1_2_5_7_2","doi-asserted-by":"publisher","DOI":"10.2169\/internalmedicine1962.26.2"},{"key":"e_1_2_5_8_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jns.2003.09.016"},{"key":"e_1_2_5_9_2","first-page":"1","volume-title":"The Research Committee on Hashimoto's Thyroiditis of the Ministry of Health and Welfare, Japan: Annual Report","author":"Torizuka K.","year":"1976"}],"container-title":["European Journal of Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1468-1331.2007.01978.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1468-1331.2007.01978.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,9]],"date-time":"2023-10-09T18:16:39Z","timestamp":1696875399000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1468-1331.2007.01978.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,10,18]]},"references-count":8,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2007,12]]}},"alternative-id":["10.1111\/j.1468-1331.2007.01978.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1468-1331.2007.01978.x","archive":["Portico"],"relation":{},"ISSN":["1351-5101","1468-1331"],"issn-type":[{"value":"1351-5101","type":"print"},{"value":"1468-1331","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,10,18]]},"assertion":[{"value":"2007-10-18","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}